OPRI has been leading the paradigm shift in real world evidence for the past 12 years, by delivering pragmatic clinical trials, disease registries and database research.
OPRI’s founder, Professor David Price, has been a pioneer in setting new quality standards for database research which are fully adhered to by the research institute. These include:
- Respiratory Effectiveness Group (REG) quality standards
- European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP)
What can we offer?
OPRI remains focused on your research questions and the optimal solutions to answer it, considering a diverse array of real-world data sources. Our integrated team of epidemiologists, biostatisticians, data analysts, health economists, medical writers and world-renowned clinicians critically assess the available databases to identify those that will yield the best information to address your research needs.
The team can provide the following services from end to end:
- proposal generation
- scientific and medical consultancy
- feasibility assessment
- study design
- protocol generation
- data specifications
- ethics approval and study registrations
- electronic data capture systems
- dataset creation
- statistical analysis
- final report generation
- abstracts and posters
- manuscript writing
Why are we different?
OPRI’s collaboration with global database organisation means it has experience in accessing real-life data, from around the world, including:
- United Kingdom (UK)
- South Korea
- United States of America (USA):
In collaboration with Optimum Patient Care UK (OPC UK), Optimum Patient Care Australia (OPC AU) and Optimum Patient Care Global (OPC Global), OPRI can deliver clinical trials, database research and disease registries anywhere in the world.
We go beyond classical scientific publications to translate findings into clinical practice via educational workshops, clinical audits and implement tools into real life practice.